A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT01283373 · COMPLETED
Trial details
- NCT number
- NCT01283373
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2016-01-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.